FDA Grand Rounds: The plasmid puzzle: finding solutions in Salmonella
July 13, 2023
Zoom Webinar
The FDA Grand Rounds is webcast every other month to highlight cutting-edge research underway across the agency and its impact on protecting and advancing public health. Each session features an FDA scientist presenting on a key public health challenge and how FDA is applying science to its regulatory activities.
New sequencing technologies help us understand how pathogens from the food supply spread antibiotic resistance, but there are some limitations to their use. This session will focus on how to improve sequencing technology use and overcome limitations.
- Meslier, V., et al., Benchmarking second and third-generation sequencing platforms for microbial metagenomics. Sci Data, 2022. 9(1): p. 694.
- Wick, R.R., et al., Trycycler: consensus long-read assemblies for bacterial genomes. Genome Biol, 2021. 22(1): p. 266.
- Wick, R.R., et al., Recovery of small plasmid sequences via Oxford Nanopore sequencing. Microb Genom, 2021. 7(8).
- Discuss the research conducted at the FDA
- Explain how FDA science impacts public health
- Discuss the strengths and limitations of different next-generation sequencing platforms and how new knowledge can help all sequencing methods
- Explain the importance of plasmids in public health and across the One Health Spectrum
- Discuss different ways that plasmids can impact the microbiome and why being able to track all of the plasmids in a system is important
This activity is intended for physicians, pharmacists, nurses, and other scientists within the agency and external scientific communities.
Lecture 1 July 13, 2023
Time | Topic | Speaker |
---|---|---|
12:00 - 1:00 PM EDT | The plasmid puzzle: finding solutions in Salmonella | Kristina Feye, PhD |
Physicians, pharmacists, nurses, and those claiming non-physician CME: participants must attest to their attendance and complete the final activity evaluation via the CE Portal (ceportal.fda.gov). For multi-day activities, participants must attest to their attendance and complete the faculty evaluation each day. Final activity evaluations must be completed within two weeks after the activity - no exceptions.
Attention Pharmacists and Pharmacy Techs: Failure to provide your correct NABP AND Date of Birth information, in the required format, may result in the loss of credit for this activity. NABP profile number should be the 6-7 digit profile number assigned by the CPE Monitor and your birth date should be in the MMDD format (e.g. 0721) Do not provide your pharmacy license number. Please click the "My Account" tab and then navigate to "Edit Contact Information" to verify that your information is correct.
Attendees have 14 days from the last day of the activity to log in, complete the required evaluation(s) and attest to your attendance to claim credit.Physicians and nurses may then view/print statement of credit. Pharmacists should log into the CPE monitor 8 weeks after the last session of the activity to obtain their CE credit.
Faculty
- Feye, Kristina, PhD, Research Microbiologist, NCTR-FDA - nothing to disclose
Planning Committee
- Dinatale, Miriam, DO, Team Leader, Food and Drug Administration - nothing to disclose
- Pfundt, Tiffany, PharmD, Program Coordinator, FDA/CDER/OTBB - nothing to disclose
- Wheelock, Leslie, RN, MS, Director, OSPD, FDA, OC, OCS, OSPD - nothing to disclose
CE Consultation and Accreditation Team
- Bueide, Rachel E., MPhil, Training Specialist, FDA/CDER/OEP/DLOD - nothing to disclose
- Bryant, Traci, M.A.T., Lead Training Specialist, FDA/CDER/OEP/DLOD - nothing to disclose
- Wood, Sara, Accreditation Program Administrator, CECAT, FDA/CDER/OEP/DLOD - nothing to disclose
All relevant financial relationships have been mitigated.
Registration is complimentary; therefore refunds are not applicable.